About
Summary
Ph.D. in Biology with 15+ years of pharmaceutical and biotech industry experience, including 12 years in leadership roles spanning oncology, immuno-oncology, inflammation, metabolic disorders, and CNS. Proven record in advancing drug discovery programs from target identification to preclinical candidate nomination. Deep expertise in in vitro assay development, high-throughput screening (HTS), translational models, and IND-enabling studies. Recognized for strategic project leadership, client engagement, and cross-functional team management in CRO and pharma environments.
Positions
Principal Scientific Manager Oct 2022 -
· Lead in vitro biology strategy for oncology, immuno-oncology, inflammation, and CNS programs, specializing in PROTACs and targeted protein degradation.
· Directed assay development from feasibility to hit-to-lead and IND-enabling phases; miniaturized HTS assays to 1536-well formats.
· Managed client relationships across global biotech/pharma; designed and executed tailored research proposals.
· Integrated 3D organoid and Organ-on-Chip platforms for disease modeling and preclinical validation.
· Oversaw cross-disciplinary teams, delivering projects on-time and within budget.
Education
Acharya Nagarjuna University 2005 - 2008
Field of study: Microbiology
Degree: PhD
Bioactive metabolites for diverse biological activities.
Skills
• In Vitro Biology & Translational Models (2D/3D Organoids, Organ-on-Chip)
• High-Throughput Screening (384/1536-well), Assay Miniaturization
• PROTACs, Molecular Glues, Targeted Protein Degradation Platforms
• Biochemical & Cell-Based Assays (Kinase, GPCR, RNA-binding, Phenotypic)
• Flow Cytometry, Imaging, Immunohistochemistry, Biomarker Platforms
• Drug Discovery Project Leadership – Target to IND-enabling Studies
• CRO & Client Relationship Management
• Regulatory Compliance (US-FDA IND, BSL-2/3, Biosafety)
• Strategic Planning, Proposal Development, Budget Oversight
Professional interests
Advancing drug discovery through innovative in vitro assay development, high-throughput screening, and translational biology approaches across oncology, immunooncology, CNS, inflammation, and metabolic disorders. Passionate about integrating molecular and cell biology techniques with advanced preclinical models (3D organoids, organ-on-chip) to enable target validation, mechanism-of-action studies, and IND-enabling research. Committed to cross-functional collaboration, scientific leadership, and delivering impactful therapeutics from discovery to preclinical candidate nomination.
Keywords: assay development, drug discovery, HTS, in vitro, preclinical development, screening, Translational ResearchContact details
Please sign in to see contact details.New opportunities
Open to new opportunities: